世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
世界および中国における核酸ベースのマルチプレックスアッセイの市場規模、現状、予測2021-2027年Global and China Nucleic Acid-Based Multiplex Assays Market Size, Status and Forecast 2021-2027 マルチプレックスアッセイとは、様々な分析物（タンパク質、生体分子、成長因子、サイトカイン、ケモカインなど）を同時に検出・定量することでプロファイリングを行う方法です。このアッセイは、ポリメラーゼ連... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリーマルチプレックスアッセイとは、様々な分析物（タンパク質、生体分子、成長因子、サイトカイン、ケモカインなど）を同時に検出・定量することでプロファイリングを行う方法です。このアッセイは、ポリメラーゼ連鎖反応（PCR）で複数の標的を増幅し、ELISAなどの従来の方法と比較して、より少ない時間で微量のタンパク質やその他の分析物からより多くの情報を収集するために使用されます。マルチプレックスアッセイは、病原体の同定、突然変異解析、RNA 検出、遺伝子検出解析、連鎖解析、法医学研究などに広く利用されています。市場分析とインサイト核酸ベースのマルチプレックスアッセイの世界市場 核酸ベースのマルチプレックスアッセイの世界市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルに達すると予測され、2021年から2027年の間、XX％のCAGRで推移すると予測されます。 本レポートは、業界標準の正確な分析と高いデータの整合性により、世界のNucleic Acid-Based Multiplex Assays市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つことを目的としています。本レポートの購入者は、核酸ベースマルチプレックスアッセイの世界市場全体の規模（売上高）など、検証済みの信頼できる市場予測にアクセスすることができます。 本レポートは、核酸ベースマルチプレックスアッセイの世界市場において、競合他社よりも優位に立ち、永続的な成功を収めるための効果的なツールであることがわかります。本レポートに掲載されている調査結果、データ、情報はすべて、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、核酸ベースマルチプレックスアッセイの世界市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を用いています。 世界の核酸ベースマルチプレックスアッセイの概要と市場規模 核酸ベースのマルチプレックスアッセイ市場は、企業別、地域（国）別、タイプ別、アプリケーション別に分類されます。世界のNucleic Acid-Based Multiplex Assays市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間におけるタイプ別、アプリケーション別の収益と予測に焦点を当てています。 タイプ別セグメント 試薬・消耗品 機器・アクセサリ ソフトウェア＆サービス アプリケーション別セグメント コンパニオン診断薬 研究・開発 臨床診断薬 地域別 北アメリカ 米国 カナダ ヨーロッパ ドイツ フランス イギリス イタリア ロシア 北欧 その他のヨーロッパ諸国 アジア太平洋地域 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア諸国 ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中近東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他の中東・アフリカ地域 会社別 Luminex サーモフィッシャーサイエンティフィック イルミナ バイオラッドラボ QIAGEN BD アブカム シージーン メソスケール・ダイアグノスティクス ランドックス・ラボラトリーズ 目次1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Nucleic Acid-Based Multiplex Assays Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Reagents & Consumables 1.2.3 Instruments & Accessories 1.2.4 Software & Services 1.3 Market by Application 1.3.1 Global Nucleic Acid-Based Multiplex Assays Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Companion Diagnostics 1.3.3 Research & Development 1.3.4 Clinical Diagnostics 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Nucleic Acid-Based Multiplex Assays Market Perspective (2016-2027) 2.2 Nucleic Acid-Based Multiplex Assays Growth Trends by Regions 2.2.1 Nucleic Acid-Based Multiplex Assays Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Nucleic Acid-Based Multiplex Assays Historic Market Share by Regions (2016-2021) 2.2.3 Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Regions (2022-2027) 2.3 Nucleic Acid-Based Multiplex Assays Industry Dynamic 2.3.1 Nucleic Acid-Based Multiplex Assays Market Trends 2.3.2 Nucleic Acid-Based Multiplex Assays Market Drivers 2.3.3 Nucleic Acid-Based Multiplex Assays Market Challenges 2.3.4 Nucleic Acid-Based Multiplex Assays Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Nucleic Acid-Based Multiplex Assays Players by Revenue 3.1.1 Global Top Nucleic Acid-Based Multiplex Assays Players by Revenue (2016-2021) 3.1.2 Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Players (2016-2021) 3.2 Global Nucleic Acid-Based Multiplex Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Nucleic Acid-Based Multiplex Assays Revenue 3.4 Global Nucleic Acid-Based Multiplex Assays Market Concentration Ratio 3.4.1 Global Nucleic Acid-Based Multiplex Assays Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid-Based Multiplex Assays Revenue in 2020 3.5 Nucleic Acid-Based Multiplex Assays Key Players Head office and Area Served 3.6 Key Players Nucleic Acid-Based Multiplex Assays Product Solution and Service 3.7 Date of Enter into Nucleic Acid-Based Multiplex Assays Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Nucleic Acid-Based Multiplex Assays Breakdown Data by Type 4.1 Global Nucleic Acid-Based Multiplex Assays Historic Market Size by Type (2016-2021) 4.2 Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Type (2022-2027) 5 Nucleic Acid-Based Multiplex Assays Breakdown Data by Application 5.1 Global Nucleic Acid-Based Multiplex Assays Historic Market Size by Application (2016-2021) 5.2 Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Nucleic Acid-Based Multiplex Assays Market Size (2016-2027) 6.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Type 6.2.1 North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021) 6.2.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027) 6.2.3 North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027) 6.3 North America Nucleic Acid-Based Multiplex Assays Market Size by Application 6.3.1 North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021) 6.3.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027) 6.3.3 North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027) 6.4 North America Nucleic Acid-Based Multiplex Assays Market Size by Country 6.4.1 North America Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021) 6.4.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Nucleic Acid-Based Multiplex Assays Market Size (2016-2027) 7.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type 7.2.1 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021) 7.2.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027) 7.2.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027) 7.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application 7.3.1 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021) 7.3.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027) 7.3.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027) 7.4 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country 7.4.1 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021) 7.4.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size (2016-2027) 8.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type 8.2.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027) 8.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application 8.3.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027) 8.4 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region 8.4.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size (2016-2027) 9.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type 9.2.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021) 9.2.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027) 9.2.3 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027) 9.3 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application 9.3.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021) 9.3.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027) 9.3.3 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027) 9.4 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country 9.4.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021) 9.4.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size (2016-2027) 10.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type 10.2.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027) 10.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application 10.3.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027) 10.4 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country 10.4.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Luminex 11.1.1 Luminex Company Details 11.1.2 Luminex Business Overview 11.1.3 Luminex Nucleic Acid-Based Multiplex Assays Introduction 11.1.4 Luminex Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.1.5 Luminex Recent Development 11.2 Thermo Fisher Scientific 11.2.1 Thermo Fisher Scientific Company Details 11.2.2 Thermo Fisher Scientific Business Overview 11.2.3 Thermo Fisher Scientific Nucleic Acid-Based Multiplex Assays Introduction 11.2.4 Thermo Fisher Scientific Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.2.5 Thermo Fisher Scientific Recent Development 11.3 Illumina 11.3.1 Illumina Company Details 11.3.2 Illumina Business Overview 11.3.3 Illumina Nucleic Acid-Based Multiplex Assays Introduction 11.3.4 Illumina Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.3.5 Illumina Recent Development 11.4 Bio-Rad Lab 11.4.1 Bio-Rad Lab Company Details 11.4.2 Bio-Rad Lab Business Overview 11.4.3 Bio-Rad Lab Nucleic Acid-Based Multiplex Assays Introduction 11.4.4 Bio-Rad Lab Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.4.5 Bio-Rad Lab Recent Development 11.5 QIAGEN 11.5.1 QIAGEN Company Details 11.5.2 QIAGEN Business Overview 11.5.3 QIAGEN Nucleic Acid-Based Multiplex Assays Introduction 11.5.4 QIAGEN Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.5.5 QIAGEN Recent Development 11.6 BD 11.6.1 BD Company Details 11.6.2 BD Business Overview 11.6.3 BD Nucleic Acid-Based Multiplex Assays Introduction 11.6.4 BD Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.6.5 BD Recent Development 11.7 Abcam 11.7.1 Abcam Company Details 11.7.2 Abcam Business Overview 11.7.3 Abcam Nucleic Acid-Based Multiplex Assays Introduction 11.7.4 Abcam Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.7.5 Abcam Recent Development 11.8 Seegene 11.8.1 Seegene Company Details 11.8.2 Seegene Business Overview 11.8.3 Seegene Nucleic Acid-Based Multiplex Assays Introduction 11.8.4 Seegene Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.8.5 Seegene Recent Development 11.9 Meso Scale Diagnostics 11.9.1 Meso Scale Diagnostics Company Details 11.9.2 Meso Scale Diagnostics Business Overview 11.9.3 Meso Scale Diagnostics Nucleic Acid-Based Multiplex Assays Introduction 11.9.4 Meso Scale Diagnostics Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.9.5 Meso Scale Diagnostics Recent Development 11.10 Randox Laboratories 11.10.1 Randox Laboratories Company Details 11.10.2 Randox Laboratories Business Overview 11.10.3 Randox Laboratories Nucleic Acid-Based Multiplex Assays Introduction 11.10.4 Randox Laboratories Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.10.5 Randox Laboratories Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
SummaryMultiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others. Table of Contents1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Nucleic Acid-Based Multiplex Assays Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Reagents & Consumables 1.2.3 Instruments & Accessories 1.2.4 Software & Services 1.3 Market by Application 1.3.1 Global Nucleic Acid-Based Multiplex Assays Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Companion Diagnostics 1.3.3 Research & Development 1.3.4 Clinical Diagnostics 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Nucleic Acid-Based Multiplex Assays Market Perspective (2016-2027) 2.2 Nucleic Acid-Based Multiplex Assays Growth Trends by Regions 2.2.1 Nucleic Acid-Based Multiplex Assays Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Nucleic Acid-Based Multiplex Assays Historic Market Share by Regions (2016-2021) 2.2.3 Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Regions (2022-2027) 2.3 Nucleic Acid-Based Multiplex Assays Industry Dynamic 2.3.1 Nucleic Acid-Based Multiplex Assays Market Trends 2.3.2 Nucleic Acid-Based Multiplex Assays Market Drivers 2.3.3 Nucleic Acid-Based Multiplex Assays Market Challenges 2.3.4 Nucleic Acid-Based Multiplex Assays Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Nucleic Acid-Based Multiplex Assays Players by Revenue 3.1.1 Global Top Nucleic Acid-Based Multiplex Assays Players by Revenue (2016-2021) 3.1.2 Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Players (2016-2021) 3.2 Global Nucleic Acid-Based Multiplex Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Nucleic Acid-Based Multiplex Assays Revenue 3.4 Global Nucleic Acid-Based Multiplex Assays Market Concentration Ratio 3.4.1 Global Nucleic Acid-Based Multiplex Assays Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid-Based Multiplex Assays Revenue in 2020 3.5 Nucleic Acid-Based Multiplex Assays Key Players Head office and Area Served 3.6 Key Players Nucleic Acid-Based Multiplex Assays Product Solution and Service 3.7 Date of Enter into Nucleic Acid-Based Multiplex Assays Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Nucleic Acid-Based Multiplex Assays Breakdown Data by Type 4.1 Global Nucleic Acid-Based Multiplex Assays Historic Market Size by Type (2016-2021) 4.2 Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Type (2022-2027) 5 Nucleic Acid-Based Multiplex Assays Breakdown Data by Application 5.1 Global Nucleic Acid-Based Multiplex Assays Historic Market Size by Application (2016-2021) 5.2 Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Nucleic Acid-Based Multiplex Assays Market Size (2016-2027) 6.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Type 6.2.1 North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021) 6.2.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027) 6.2.3 North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027) 6.3 North America Nucleic Acid-Based Multiplex Assays Market Size by Application 6.3.1 North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021) 6.3.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027) 6.3.3 North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027) 6.4 North America Nucleic Acid-Based Multiplex Assays Market Size by Country 6.4.1 North America Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021) 6.4.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Nucleic Acid-Based Multiplex Assays Market Size (2016-2027) 7.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type 7.2.1 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021) 7.2.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027) 7.2.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027) 7.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application 7.3.1 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021) 7.3.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027) 7.3.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027) 7.4 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country 7.4.1 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021) 7.4.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size (2016-2027) 8.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type 8.2.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027) 8.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application 8.3.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027) 8.4 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region 8.4.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size (2016-2027) 9.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type 9.2.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021) 9.2.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027) 9.2.3 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027) 9.3 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application 9.3.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021) 9.3.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027) 9.3.3 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027) 9.4 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country 9.4.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021) 9.4.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size (2016-2027) 10.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type 10.2.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027) 10.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application 10.3.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027) 10.4 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country 10.4.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Luminex 11.1.1 Luminex Company Details 11.1.2 Luminex Business Overview 11.1.3 Luminex Nucleic Acid-Based Multiplex Assays Introduction 11.1.4 Luminex Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.1.5 Luminex Recent Development 11.2 Thermo Fisher Scientific 11.2.1 Thermo Fisher Scientific Company Details 11.2.2 Thermo Fisher Scientific Business Overview 11.2.3 Thermo Fisher Scientific Nucleic Acid-Based Multiplex Assays Introduction 11.2.4 Thermo Fisher Scientific Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.2.5 Thermo Fisher Scientific Recent Development 11.3 Illumina 11.3.1 Illumina Company Details 11.3.2 Illumina Business Overview 11.3.3 Illumina Nucleic Acid-Based Multiplex Assays Introduction 11.3.4 Illumina Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.3.5 Illumina Recent Development 11.4 Bio-Rad Lab 11.4.1 Bio-Rad Lab Company Details 11.4.2 Bio-Rad Lab Business Overview 11.4.3 Bio-Rad Lab Nucleic Acid-Based Multiplex Assays Introduction 11.4.4 Bio-Rad Lab Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.4.5 Bio-Rad Lab Recent Development 11.5 QIAGEN 11.5.1 QIAGEN Company Details 11.5.2 QIAGEN Business Overview 11.5.3 QIAGEN Nucleic Acid-Based Multiplex Assays Introduction 11.5.4 QIAGEN Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.5.5 QIAGEN Recent Development 11.6 BD 11.6.1 BD Company Details 11.6.2 BD Business Overview 11.6.3 BD Nucleic Acid-Based Multiplex Assays Introduction 11.6.4 BD Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.6.5 BD Recent Development 11.7 Abcam 11.7.1 Abcam Company Details 11.7.2 Abcam Business Overview 11.7.3 Abcam Nucleic Acid-Based Multiplex Assays Introduction 11.7.4 Abcam Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.7.5 Abcam Recent Development 11.8 Seegene 11.8.1 Seegene Company Details 11.8.2 Seegene Business Overview 11.8.3 Seegene Nucleic Acid-Based Multiplex Assays Introduction 11.8.4 Seegene Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.8.5 Seegene Recent Development 11.9 Meso Scale Diagnostics 11.9.1 Meso Scale Diagnostics Company Details 11.9.2 Meso Scale Diagnostics Business Overview 11.9.3 Meso Scale Diagnostics Nucleic Acid-Based Multiplex Assays Introduction 11.9.4 Meso Scale Diagnostics Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.9.5 Meso Scale Diagnostics Recent Development 11.10 Randox Laboratories 11.10.1 Randox Laboratories Company Details 11.10.2 Randox Laboratories Business Overview 11.10.3 Randox Laboratories Nucleic Acid-Based Multiplex Assays Introduction 11.10.4 Randox Laboratories Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021) 11.10.5 Randox Laboratories Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
QYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD（nucleic）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
